Mr. Dilip Shanghvi
Chairman and Managing Director - Sun Pharmaceutical Industries Limited
Mr. Dilip Shanghvi is the Chairman and Managing Director of Sun Pharmaceutical Industries Limited (Sun Pharma), world's 4th largest and India's No. 1 specialty generic pharmaceutical company. He is also the Chairman of Sun Pharma Advanced Research Company, which is engaged in R&D of new innovative drugs and delivery technologies.
He was honoured with India's fourth highest Civilian Award, the Padma Shri, in recognition of his distinguished contribution to the Indian Trade & Industry, in 2016. In 2018, the Indian Government appointed Mr. Shanghvi to India's central bank, Reserve Bank of India’s 21-member Central Board Committee. He is part of the Economic Advisory Council formed by the Government of Maharashtra, India to achieve rapid and comprehensive development in the state. The Government of Gujarat appointed him as the Chairman of Gujarat Biotechnology University in 2022
Mr. Shanghvi has been conferred with many awards and recognitions. In 2023, 2021 & 2020, India’s leading magazine, India Today has included him in its Annual Power List of 50 influential personalities in India. Some of the other awards and recognitions bestowed on him include: Moneycontrol Lifetime Achievement Award (2023), NDTV Business Leader of the Year (2015), Forbes Entrepreneur for the year (2014), Economic Times’ Business Leader of the Year (2014) and Ernst and Young’s World Entrepreneur of the Year (2011). He has also been awarded the Economic Times’ Entrepreneur of the Year (2008), Business Standard’s CEO of the Year (2008) and CNBC TV 18’s First Generation Entrepreneur of the Year (2007).
He is a former President of the Indian Pharmaceutical Alliance (IPA) and has also served as the Chairman of the Board of Governors of the Indian Institute of Technology (Bombay). He is a former Trustee of the prestigious Rhodes Scholarship Programme at Oxford University.
In 2019, he was conferred with an honorary doctorate by the Tel Aviv University, Israel’s largest and most comprehensive institution of higher learning.
Mr. Shanghvi has played a key role in the global reach of the Indian pharmaceutical industry and continues to inspire generations of entrepreneurs in their journey to success.
Bringing a Silent Revolution through the Boardroom
Institute of Directors (IOD) is an apex national association of Corporate Directors under the India's 'Societies Registration Act XXI of 1860'. Currently it is associated with over 30,000 senior executives from Govt, PSU and Private organizations of India and abroad.
Owned by: Institute of Directors, India
Disclaimer: The opinions expressed in the articles/ stories are the personal opinions of the author. IOD/ Editor is not responsible for the accuracy, completeness, suitability, or validity of any information in those articles. The information, facts or opinions expressed in the articles/ speeches do not reflect the views of IOD/ Editor and IOD/ Editor does not assume any responsibility or liability for the same.
About Publisher
Bringing a Silent Revolution through the Boardroom
Institute of Directors (IOD) is an apex national association of Corporate Directors under the India's 'Societies Registration Act XXI of 1860'. Currently it is associated with over 30,000 senior executives from Govt, PSU and Private organizations of India and abroad.
View All BlogsMasterclass for Directors
Categories